| 2025-09-02 |
13D
|
STTK / Shattuck Labs, Inc.
|
|
|
6,306,127 |
|
|
|
| 2025-08-15 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
15,219,994 |
15,219,994 |
|
|
|
| 2025-08-14 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
8,461,500 |
|
|
|
| 2025-08-14 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
3,406,335 |
2,614,184 |
|
|
|
| 2025-08-14 |
13G/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
967,000 |
967,000 |
|
|
|
| 2025-08-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
2,862,448 |
1,333,333 |
|
|
|
| 2025-08-14 |
13G/A
|
|
|
|
134,947 |
|
|
|
| 2025-08-13 |
13D/A
|
AVBP / ArriVent BioPharma, Inc.
|
|
3,027,328 |
3,027,328 |
|
|
|
| 2025-07-30 |
13D/A
|
IKNA / Ikena Oncology, Inc.
|
|
8,008,913 |
773,754 |
|
|
|
| 2025-07-24 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
243,878 |
132,473 |
|
|
|
| 2025-07-21 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
5,923,534 |
243,878 |
|
|
|
| 2025-07-09 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
6,650,000 |
5,923,534 |
|
|
|
| 2025-06-18 |
13D/A
|
IKNA / Ikena Oncology, Inc.
|
|
2,189,111 |
8,008,913 |
|
|
|
| 2025-06-17 |
13D/A
|
ELVN / Enliven Therapeutics, Inc.
|
|
7,918,163 |
7,918,163 |
|
|
|
| 2025-05-15 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
2,133,405 |
2,133,405 |
|
|
|
| 2025-05-15 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
3,406,335 |
3,406,335 |
|
|
|
| 2025-05-15 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
2,925,900 |
4,655,600 |
|
|
|
| 2025-05-15 |
13G
|
WHWK / Whitehawk Therapeutics, Inc.
|
|
|
4,166,000 |
|
|
|
| 2025-05-15 |
13G/A
|
VSTM / Verastem, Inc.
|
|
4,148,862 |
2,862,448 |
|
|
|
| 2025-05-14 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
9,785,423 |
9,785,423 |
|
|
|
| 2025-05-12 |
13D/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
14,756,096 |
15,252,867 |
|
|
|
| 2025-05-01 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
6,943,654 |
9,785,423 |
|
|
|
| 2025-04-25 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
7,404,869 |
6,650,000 |
|
|
|
| 2025-04-14 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
73,114,592 |
0 |
|
|
|
| 2025-04-11 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
18,791,422 |
15,219,994 |
|
|
|
| 2025-03-12 |
13D/A
|
IRON / Disc Medicine, Inc.
|
|
1,785,571 |
1,556,369 |
|
|
|
| 2025-02-14 |
13G
|
ADCT / ADC Therapeutics SA
|
|
|
3,437,813 |
|
|
|
| 2025-02-14 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
13,135,260 |
|
|
|
| 2025-02-14 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
589,200 |
718,200 |
|
|
|
| 2025-02-14 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
0 |
510,000 |
|
|
|
| 2025-02-13 |
13D
|
SION / Sionna Therapeutics, Inc.
|
|
|
|
|
|
|
| 2025-01-29 |
13D/A
|
TRAW / Traws Pharma, Inc.
|
|
605,531 |
760,824 |
|
|
|
| 2024-12-26 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
8,034,000 |
7,404,869 |
|
|
|
| 2024-11-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
2,960,000 |
503,400 |
|
|
|
| 2024-11-14 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
2,255,000 |
0 |
|
|
|
| 2024-11-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
3,000,000 |
2,441,275 |
|
|
|
| 2024-11-14 |
13G
|
CCCC / C4 Therapeutics, Inc.
|
|
|
2,925,900 |
|
|
|
| 2024-11-14 |
13G
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
589,200 |
|
|
|
| 2024-11-14 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
2,133,405 |
2,133,405 |
|
|
|
| 2024-11-14 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
4,003,967 |
3,406,335 |
|
|
|
| 2024-11-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
1,529,115 |
4,148,862 |
|
|
|
| 2024-11-14 |
13G
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
967,000 |
|
|
|
| 2024-11-12 |
13D/A
|
THRD / Third Harmonic Bio, Inc.
|
|
5,779,071 |
5,779,071 |
|
|
|
| 2024-11-12 |
13D/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
14,756,096 |
14,756,096 |
|
|
|
| 2024-11-08 |
13D
|
|
|
|
2,677,256 |
|
|
|
| 2024-11-06 |
13D/A
|
TRAW / Traws Pharma, Inc.
|
|
602,000 |
605,531 |
|
|
|
| 2024-10-25 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
2,124,267 |
1,182,717 |
|
|
|
| 2024-10-17 |
13D
|
UPB / Upstream Bio, Inc.
|
|
|
4,554,873 |
|
|
|
| 2024-10-01 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
2,437,967 |
2,124,267 |
|
|
|
| 2024-09-23 |
13D
|
TRAW / Traws Pharma, Inc.
|
|
|
602,000 |
|
|
|
| 2024-09-23 |
13D
|
MBX / MBX Biosciences, Inc.
|
|
|
3,812,215 |
|
|
|
| 2024-09-16 |
13D/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
7,562,971 |
7,562,971 |
|
|
|
| 2024-09-10 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
73,114,592 |
73,114,592 |
|
|
|
| 2024-08-15 |
13D/A
|
SCPH / scPharmaceuticals Inc.
|
|
5,559,528 |
6,059,528 |
|
|
|
| 2024-08-15 |
13D/A
|
APLM / Apollomics, Inc.
|
|
8,615,456 |
50,000 |
|
|
|
| 2024-08-09 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
2,649,464 |
1,965,266 |
|
|
|
| 2024-07-18 |
13D/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
7,619,135 |
7,562,971 |
|
|
|
| 2024-07-02 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
2,866,267 |
2,437,967 |
|
|
|
| 2024-06-20 |
13D/A
|
IRON / Disc Medicine, Inc.
|
|
1,702,237 |
1,785,571 |
|
|
|
| 2024-05-22 |
13D/A
|
APLM / Apollomics, Inc.
|
|
8,615,456 |
8,615,456 |
|
|
|
| 2024-05-20 |
13D/A
|
ELVN / Enliven Therapeutics, Inc.
|
|
8,951,463 |
7,918,163 |
|
|
|
| 2024-05-08 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
6,943,654 |
6,943,654 |
|
|
|
| 2024-04-12 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
8,034,000 |
8,034,000 |
|
|
|
| 2024-04-04 |
13D/A
|
ELVN / Enliven Therapeutics, Inc.
|
|
8,949,339 |
8,951,463 |
|
|
|
| 2024-03-28 |
13D
|
QTTB / Q32 Bio Inc.
|
|
|
2,252,987 |
|
|
|
| 2024-03-22 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
18,791,422 |
18,791,422 |
|
|
|
| 2024-03-21 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
9,772,598 |
9,772,598 |
|
|
|
| 2024-03-08 |
13D/A
|
NXTC / NextCure, Inc.
|
|
2,711,013 |
1,268,013 |
|
|
|
| 2024-02-21 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
7,559,729 |
7,559,729 |
|
|
|
| 2024-02-14 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
2,266,000 |
2,255,000 |
|
|
|
| 2024-02-14 |
13G
|
NSPR / InspireMD, Inc.
|
|
|
2,133,405 |
|
|
|
| 2024-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
10,328,649 |
11,494,437 |
|
|
|
| 2024-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
|
1,529,115 |
|
|
|
| 2024-02-14 |
13G/A
|
SIBN / SI-BONE, Inc.
|
|
3,201,100 |
2,144,631 |
|
|
|
| 2024-02-14 |
13G
|
SRRK / Scholar Rock Holding Corporation
|
|
|
2,960,000 |
|
|
|
| 2024-02-14 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
671,741 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
4,012,281 |
4,003,967 |
|
|
|
| 2024-02-14 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
7,082,837 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
10,378,591 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
3,495,122 |
1,927,000 |
|
|
|
| 2024-02-14 |
13G
|
ELEV / Elevation Oncology, Inc.
|
|
|
3,000,000 |
|
|
|
| 2024-02-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
3,196,876 |
1,667,360 |
|
|
|
| 2024-02-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
7,300,921 |
0 |
|
|
|
| 2024-02-05 |
13D/A
|
CALC / CalciMedica, Inc.
|
|
297,380 |
297,380 |
|
|
|
| 2024-02-05 |
13D
|
AVBP / ArriVent BioPharma, Inc.
|
|
|
3,027,328 |
|
|
|
| 2024-01-29 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
6,647,598 |
9,772,598 |
|
|
|
| 2024-01-25 |
13D/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
14,301,551 |
14,756,096 |
|
|
|
| 2023-12-29 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
4,226,843 |
2,680,496 |
|
|
|
| 2023-12-27 |
13D/A
|
INVA / Innoviva, Inc.
|
|
17,713,600 |
17,713,600 |
|
|
|
| 2023-12-15 |
13D/A
|
IRON / Disc Medicine, Inc.
|
|
2,269,637 |
1,702,237 |
|
|
|
| 2023-12-13 |
13D/A
|
KROS / Keros Therapeutics, Inc.
|
|
1,268,734 |
1,268,734 |
|
|
|
| 2023-12-06 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
4,178,588 |
3,567,159 |
|
|
|
| 2023-11-29 |
13D/A
|
APLM / Apollomics, Inc.
|
|
|
8,615,456 |
|
|
|
| 2023-11-24 |
13D/A
|
INVA / Innoviva, Inc.
|
|
17,713,600 |
17,713,600 |
|
|
|
| 2023-11-20 |
13D/A
|
APLM / Apollomics, Inc.
|
|
|
9,533,158 |
|
|
|
| 2023-11-17 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
7,559,729 |
7,559,729 |
|
|
|
| 2023-11-14 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
7,559,729 |
7,559,729 |
|
|
|
| 2023-11-13 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
4,081,592 |
4,226,843 |
|
|
|
| 2023-11-01 |
13D/A
|
APLM / Apollomics, Inc.
|
|
|
16,233,158 |
|
|
|
| 2023-10-04 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
6,029,995 |
401,998 |
|
|
|
| 2023-10-02 |
13D/A
|
APLM / Apollomics, Inc.
|
|
|
18,043,635 |
|
|
|
| 2023-09-21 |
13D/A
|
IKNA / Ikena Oncology, Inc.
|
|
2,342,232 |
2,189,111 |
|
|
|
| 2023-09-18 |
13D/A
|
GLTO / Galecto, Inc.
|
|
1,149,694 |
749,557 |
|
|
|
| 2023-09-14 |
13D/A
|
IKNA / Ikena Oncology, Inc.
|
|
1,936,886 |
2,342,232 |
|
|
|
| 2023-09-05 |
13D/A
|
GLTO / Galecto, Inc.
|
|
1,607,579 |
1,149,694 |
|
|
|
| 2023-08-23 |
13D/A
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
6,589,330 |
6,563,077 |
|
|
|
| 2023-08-17 |
13D/A
|
GLTO / Galecto, Inc.
|
|
2,241,440 |
1,607,579 |
|
|
|
| 2023-08-11 |
13D/A
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
7,583,576 |
7,641,531 |
|
|
|
| 2023-08-03 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
73,114,592 |
73,114,592 |
|
|
|
| 2023-08-02 |
13D/A
|
GLTO / Galecto, Inc.
|
|
2,455,640 |
2,241,440 |
|
|
|
| 2023-07-24 |
13D
|
TSBX / Turnstone Biologics Corp.
|
|
|
3,099,265 |
|
|
|
| 2023-07-19 |
13D/A
|
INVA / Innoviva, Inc.
|
|
17,233,668 |
17,713,600 |
|
|
|
| 2023-07-17 |
13D/A
|
GLTO / Galecto, Inc.
|
|
2,696,654 |
2,455,640 |
|
|
|
| 2023-06-29 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
6,841,423 |
8,034,000 |
|
|
|
| 2023-06-29 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
6,147,599 |
6,647,598 |
|
|
|
| 2023-06-21 |
13D/A
|
IRON / Disc Medicine, Inc.
|
|
2,160,941 |
2,269,637 |
|
|
|
| 2023-05-24 |
13D
|
VECT / VectivBio Holding AG
|
|
6,713,561 |
5,156,561 |
|
|
|
| 2023-05-24 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
14,847,077 |
15,716,642 |
|
|
|
| 2023-05-17 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
4,985,000 |
4,178,588 |
|
|
|
| 2023-05-16 |
13D/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
4,260,691 |
3,777,778 |
|
|
|
| 2023-05-16 |
13D/A
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
2,930,670 |
2,930,670 |
|
|
|
| 2023-05-08 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
6,098,797 |
7,559,729 |
|
|
|
| 2023-05-05 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
73,114,592 |
73,114,592 |
|
|
|
| 2023-05-03 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
4,693,629 |
6,098,797 |
|
|
|
| 2023-04-21 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
3,058,267 |
2,866,267 |
|
|
|
| 2023-04-12 |
13D
|
APLM / Apollomics, Inc.
|
|
|
662,561 |
|
|
|
| 2023-04-07 |
13D/A
|
GLTO / Galecto, Inc.
|
|
2,771,444 |
2,696,654 |
|
|
|
| 2023-03-31 |
13D
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
5,970,672 |
7,583,576 |
|
|
|
| 2023-03-29 |
13D/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
7,619,135 |
7,619,135 |
|
|
|
| 2023-03-24 |
13D/A
|
ETNB / 89bio, Inc.
|
|
1,504,436 |
0 |
|
|
|
| 2023-03-24 |
13D/A
|
CALC / CalciMedica, Inc.
|
|
297,380 |
297,380 |
|
|
|
| 2023-03-22 |
13D/A
|
CALC / CalciMedica, Inc.
|
|
|
297,380 |
|
|
|
| 2023-03-14 |
13D/A
|
INVA / Innoviva, Inc.
|
|
16,838,668 |
17,233,668 |
|
|
|
| 2023-02-28 |
13D/A
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
2,930,670 |
|
|
|
| 2023-02-28 |
13D
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
8,949,339 |
|
|
|
| 2023-02-23 |
13D/A
|
KNTE / Kinnate Biopharma Inc.
|
|
3,397,929 |
4,693,629 |
|
|
|
| 2023-02-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
2,100,681 |
7,300,921 |
|
|
|
| 2023-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,836,349 |
10,328,649 |
|
|
|
| 2023-02-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
10,519,240 |
0 |
|
|
|
| 2023-02-14 |
13G
|
VSTM / Verastem, Inc.
|
|
|
16,503,237 |
|
|
|
| 2023-02-14 |
13G/A
|
VECT / VectivBio Holding AG
|
|
4,903,504 |
6,713,561 |
|
|
|
| 2023-02-14 |
13G/A
|
TBPH / Theravance Biopharma, Inc.
|
|
5,456,780 |
0 |
|
|
|
| 2023-02-14 |
13G/A
|
SONX / Sonendo, Inc.
|
|
1,968,180 |
0 |
|
|
|
| 2023-02-14 |
13G/A
|
SIBN / SI-BONE, Inc.
|
|
|
3,201,100 |
|
|
|
| 2023-02-14 |
13G/A
|
RXST / RxSight, Inc.
|
|
1,062,500 |
923,733 |
|
|
|
| 2023-02-14 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
4,012,281 |
4,012,281 |
|
|
|
| 2023-02-14 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
671,741 |
671,741 |
|
|
|
| 2023-02-14 |
13G
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
7,082,837 |
|
|
|
| 2023-02-14 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
6,063,345 |
10,378,591 |
|
|
|
| 2023-02-14 |
13G/A
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
5,970,672 |
5,970,672 |
|
|
|
| 2023-02-14 |
13G/A
|
MGTX / MeiraGTx Holdings plc
|
|
3,593,966 |
0 |
|
|
|
| 2023-02-14 |
13G/A
|
HARP / Harpoon Therapeutics, Inc.
|
|
1,667,900 |
804,206 |
|
|
|
| 2023-02-14 |
13G/A
|
JNCE / Jounce Therapeutics Inc
|
|
2,200,200 |
0 |
|
|
|
| 2023-02-14 |
13G
|
KZR / Kezar Life Sciences, Inc.
|
|
|
3,495,122 |
|
|
|
| 2023-02-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
3,196,876 |
3,196,876 |
|
|
|
| 2023-02-14 |
13G
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
2,266,000 |
|
|
|
| 2023-02-14 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
1,350,602 |
0 |
|
|
|
| 2023-02-14 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
3,956,124 |
1,797,221 |
|
|
|
| 2023-01-26 |
13D/A
|
ETNB / 89bio, Inc.
|
|
1,829,436 |
1,504,436 |
|
|
|
| 2023-01-05 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
5,599,842 |
4,985,000 |
|
|
|
| 2023-01-03 |
13D/A
|
IRON / Disc Medicine, Inc.
|
|
5,826,224 |
2,160,941 |
|
|
|
| 2022-12-28 |
13D/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
7,481,204 |
7,619,135 |
|
|
|
| 2022-12-27 |
13D/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,212,571 |
1,787,569 |
|
|
|
| 2022-12-27 |
13D/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
5,028,174 |
4,260,691 |
|
|
|
| 2022-11-30 |
13D/A
|
SPRY / ARS Pharmaceuticals, Inc.
|
|
7,788,511 |
7,788,510 |
|
|
|
| 2022-11-29 |
13D/A
|
SCPH / scPharmaceuticals Inc.
|
|
4,797,148 |
5,559,528 |
|
|
|
| 2022-11-25 |
13D/A
|
TCDA / Tricida Inc
|
|
9,617,912 |
666,667 |
|
|
|
| 2022-11-10 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
18,071,547 |
18,791,422 |
|
|
|
| 2022-11-07 |
13D/A
|
KROS / Keros Therapeutics, Inc.
|
|
1,268,734 |
1,268,734 |
|
|
|
| 2022-09-28 |
13D
|
THRD / Third Harmonic Bio, Inc.
|
|
|
5,779,071 |
|
|
|
| 2022-09-27 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
4,226,843 |
4,081,592 |
|
|
|
| 2022-09-16 |
13D/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
3,042,764 |
14,301,551 |
|
|
|
| 2022-09-14 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
6,186,307 |
5,599,842 |
|
|
|
| 2022-08-30 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
72,873,494 |
73,114,592 |
|
|
|
| 2022-08-26 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
3,146,724 |
2,828,356 |
|
|
|
| 2022-08-19 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
3,058,267 |
3,058,267 |
|
|
|
| 2022-08-18 |
13D/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
3,791,204 |
7,481,204 |
|
|
|
| 2022-08-12 |
13D/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
11,871,112 |
5,028,174 |
|
|
|
| 2022-08-08 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
3,534,537 |
3,146,724 |
|
|
|
| 2022-07-05 |
13D/A
|
ETNB / 89bio, Inc.
|
|
1,864,721 |
1,829,436 |
|
|
|
| 2022-06-28 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
3,840,564 |
3,534,537 |
|
|
|
| 2022-05-05 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
5,947,323 |
6,841,423 |
|
|
|
| 2022-04-08 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
4,267,564 |
3,840,564 |
|
|
|
| 2022-04-01 |
13D/A
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
6,589,330 |
6,589,330 |
|
|
|
| 2022-03-15 |
13D/A
|
SRRA / Sierra Oncology Inc
|
|
3,044,753 |
3,044,753 |
|
|
|
| 2022-02-11 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
1,711,305 |
631,000 |
|
|
|
| 2022-02-11 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,835,993 |
1,836,349 |
|
|
|
| 2022-02-11 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
|
0 |
|
|
|
| 2022-02-11 |
13G
|
VECT / VectivBio Holding AG
|
|
4,830,004 |
4,903,504 |
|
|
|
| 2022-02-11 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
9,778,800 |
10,519,240 |
|
|
|
| 2022-02-11 |
13G/A
|
HARP / Harpoon Therapeutics, Inc.
|
|
1,020,704 |
1,667,900 |
|
|
|
| 2022-02-11 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,986,869 |
0 |
|
|
|
| 2022-02-11 |
13G/A
|
/ Pandion Therapeutics Inc
|
|
1,040,825 |
0 |
|
|
|
| 2022-02-11 |
13G
|
SONX / Sonendo, Inc.
|
|
|
1,968,180 |
|
|
|
| 2022-02-11 |
13G/A
|
NPCE / NeuroPace, Inc.
|
|
4,012,281 |
4,012,281 |
|
|
|
| 2022-02-11 |
13G/A
|
TBPH / Theravance Biopharma, Inc.
|
|
5,544,212 |
5,456,780 |
|
|
|
| 2022-02-11 |
13G/A
|
OTIC / Otonomy Inc
|
|
2,480,800 |
0 |
|
|
|
| 2022-02-11 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
|
671,741 |
|
|
|
| 2022-02-11 |
13G
|
RXST / RxSight, Inc.
|
|
|
1,062,500 |
|
|
|
| 2022-02-11 |
13G
|
JNCE / Jounce Therapeutics Inc
|
|
|
2,200,200 |
|
|
|
| 2022-02-11 |
13G/A
|
MGTX / MeiraGTx Holdings plc
|
|
3,969,425 |
3,593,966 |
|
|
|
| 2022-02-11 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
4,518,356 |
6,063,345 |
|
|
|
| 2022-02-11 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
2,753,567 |
3,196,876 |
|
|
|
| 2022-02-11 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
732,323 |
0 |
|
|
|
| 2022-02-11 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
635,766 |
0 |
|
|
|
| 2022-02-11 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
3,499,246 |
3,416,871 |
|
|
|
| 2022-02-11 |
13G
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
29,853,364 |
5,970,672 |
|
|
|
| 2022-02-11 |
13G
|
CBIO / Crescent Biopharma, Inc.
|
|
|
1,350,602 |
|
|
|
| 2022-02-11 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
1,666,825 |
2,100,681 |
|
|
|
| 2022-02-11 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
5,015,524 |
3,956,124 |
|
|
|
| 2022-02-11 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
4,845,247 |
0 |
|
|
|
| 2022-02-02 |
13D/A
|
SRRA / Sierra Oncology Inc
|
|
3,044,753 |
3,044,753 |
|
|
|
| 2021-12-17 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
|
2,649,464 |
|
|
|
| 2021-12-14 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
5,933,314 |
6,147,599 |
|
|
|
| 2021-12-06 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
9,520,000 |
4,024,821 |
|
|
|
| 2021-11-18 |
13D/A
|
/ THESEUS PHARMACEUTICALS INC
|
|
|
16,838,668 |
|
|
|
| 2021-11-18 |
13D/A
|
AFIB / Acutus Medical, Inc.
|
|
6,881,953 |
2,648,386 |
|
|
|
| 2021-11-12 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,216,206 |
4,226,843 |
|
|
|
| 2021-11-09 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
12,714,404 |
18,071,547 |
|
|
|
| 2021-11-05 |
13D/A
|
SRRA / Sierra Oncology Inc
|
|
18,660,402 |
3,044,753 |
|
|
|
| 2021-11-03 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
6,943,654 |
6,943,654 |
|
|
|
| 2021-11-02 |
13D/A
|
RPTX / Repare Therapeutics Inc.
|
|
3,276,325 |
3,177,041 |
|
|
|
| 2021-10-19 |
13D
|
/ THESEUS PHARMACEUTICALS INC
|
|
|
16,838,668 |
|
|
|
| 2021-10-14 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
4,714,195 |
0 |
|
|
|
| 2021-09-29 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
3,696,662 |
6,029,995 |
|
|
|
| 2021-09-22 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
8,053,298 |
6,943,654 |
|
|
|
| 2021-09-03 |
13D/A
|
AADI / Aadi Bioscience, Inc.
|
|
|
346,262 |
|
|
|
| 2021-09-03 |
13D/A
|
BLU / Bellus Health Inc
|
|
3,954,800 |
2,954,800 |
|
|
|
| 2021-08-31 |
13D/A
|
AFIB / Acutus Medical, Inc.
|
|
5,810,525 |
6,881,953 |
|
|
|
| 2021-08-16 |
13D/A
|
IKNA / Ikena Oncology, Inc.
|
|
1,936,886 |
1,936,886 |
|
|
|
| 2021-08-12 |
13D/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,467,292 |
2,212,571 |
|
|
|
| 2021-08-04 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
8,053,298 |
8,053,298 |
|
|
|
| 2021-07-14 |
13D/A
|
CMPX / Compass Therapeutics, Inc.
|
|
|
12,714,404 |
|
|
|
| 2021-07-14 |
13D/A
|
AFIB / Acutus Medical, Inc.
|
|
5,810,525 |
5,810,525 |
|
|
|
| 2021-06-22 |
13D
|
EWTX / Edgewise Therapeutics, Inc.
|
|
13,679,055 |
3,042,764 |
|
|
|
| 2021-04-29 |
13G
|
NPCE / NeuroPace, Inc.
|
|
|
4,012,281 |
|
|
|
| 2021-04-22 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
2,029,996 |
3,696,662 |
|
|
|
| 2021-04-20 |
13G
|
VECT / VectivBio Holding AG
|
|
|
4,830,004 |
|
|
|
| 2021-04-20 |
13G
|
VECT / VectivBio Holding AG
|
|
1,724,379 |
4,830,004 |
|
|
|
| 2021-04-15 |
13D
|
IKNA / Ikena Oncology, Inc.
|
|
1,936,886 |
1,936,886 |
|
|
|
| 2021-04-15 |
13D
|
IKNA / Ikena Oncology, Inc.
|
|
1,936,886 |
1,936,886 |
|
|
|
| 2021-04-09 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
72,803,072 |
72,873,494 |
|
|
|
| 2021-04-08 |
13D
|
EWTX / Edgewise Therapeutics, Inc.
|
|
13,679,055 |
13,679,055 |
|
|
|
| 2021-04-08 |
13D
|
EWTX / Edgewise Therapeutics, Inc.
|
|
13,679,055 |
13,679,055 |
|
|
|
| 2021-04-07 |
13D/A
|
TPTX / Turning Point Therapeutics Inc
|
|
2,027,550 |
1,743,950 |
|
|
|
| 2021-03-29 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
2,029,996 |
2,029,996 |
|
|
|
| 2021-03-26 |
13D/A
|
GRAY / Graybug Vision Inc
|
|
4,163,347 |
4,163,347 |
|
|
|
| 2021-03-25 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,248,993 |
1,835,993 |
|
|
|
| 2021-03-22 |
13D/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,467,292 |
2,467,292 |
|
|
|
| 2021-03-22 |
13D/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,765,717 |
2,467,292 |
|
|
|
| 2021-03-04 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
6,186,307 |
6,186,307 |
|
|
|
| 2021-03-04 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
7,406,307 |
6,186,307 |
|
|
|
| 2021-03-02 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
4,714,195 |
4,714,195 |
|
|
|
| 2021-03-02 |
13D
|
DBTX / Decibel Therapeutics Inc
|
|
4,061,774 |
4,061,774 |
|
|
|
| 2021-03-02 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
4,714,195 |
4,714,195 |
|
|
|
| 2021-03-02 |
13D
|
DBTX / Decibel Therapeutics Inc
|
|
4,061,774 |
4,061,774 |
|
|
|
| 2021-02-26 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
72,810,381 |
72,803,072 |
|
|
|
| 2021-02-23 |
13D
|
TERN / Terns Pharmaceuticals, Inc.
|
|
3,791,204 |
3,791,204 |
|
|
|
| 2021-02-23 |
13D
|
TERN / Terns Pharmaceuticals, Inc.
|
|
3,791,204 |
3,791,204 |
|
|
|
| 2021-02-22 |
13D
|
GMTX / Gemini Therapeutics Inc
|
|
|
5,826,224 |
|
|
|
| 2021-02-19 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
5,513,015 |
5,933,314 |
|
|
|
| 2021-02-17 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
6,767,584 |
8,053,298 |
|
|
|
| 2021-02-12 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
849,254 |
1,666,825 |
|
|
|
| 2021-02-12 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
634,812 |
1,711,305 |
|
|
|
| 2021-02-12 |
13G
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
9,778,800 |
|
|
|
| 2021-02-12 |
13G
|
TBPH / Theravance Biopharma, Inc.
|
|
|
5,544,212 |
|
|
|
| 2021-02-12 |
13G
|
SBBP / Strongbridge Biopharma plc
|
|
|
2,986,869 |
|
|
|
| 2021-02-12 |
13G
|
OTIC / Otonomy Inc
|
|
1,397,567 |
2,480,800 |
|
|
|
| 2021-02-12 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
2,288,439 |
1,485,458 |
|
|
|
| 2021-02-12 |
13G/A
|
OBSV / ObsEva SA.
|
|
2,605,531 |
0 |
|
|
|
| 2021-02-12 |
13G
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
4,518,356 |
|
|
|
| 2021-02-12 |
13G/A
|
MGTX / MeiraGTx Holdings plc
|
|
3,448,820 |
3,969,425 |
|
|
|
| 2021-02-12 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
732,323 |
|
|
|
| 2021-02-12 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
933,508 |
0 |
|
|
|
| 2021-02-12 |
13G/A
|
INSP / Inspire Medical Systems, Inc.
|
|
1,347,000 |
0 |
|
|
|
| 2021-02-12 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
3,447,840 |
4,714,195 |
|
|
|
| 2021-02-12 |
13G/A
|
HARP / Harpoon Therapeutics, Inc.
|
|
1,360,704 |
1,020,704 |
|
|
|
| 2021-02-12 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
635,766 |
|
|
|
| 2021-02-12 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
2,039,282 |
2,753,567 |
|
|
|
| 2021-02-12 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
0 |
3,499,246 |
|
|
|
| 2021-02-12 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
2,865,524 |
5,015,524 |
|
|
|
| 2021-02-12 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
3,944,090 |
4,845,247 |
|
|
|
| 2021-02-09 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
4,267,564 |
4,267,564 |
|
|
|
| 2021-01-29 |
13D/A
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
13,822,463 |
0 |
|
|
|
| 2021-01-28 |
13D/A
|
PASG / Passage Bio, Inc.
|
|
5,947,323 |
5,947,323 |
|
|
|
| 2021-01-21 |
13D
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
|
29,853,364 |
|
|
|
| 2021-01-14 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
14,847,077 |
14,847,077 |
|
|
|
| 2021-01-14 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
14,805,377 |
14,847,077 |
|
|
|
| 2020-12-30 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,816,206 |
3,216,206 |
|
|
|
| 2020-12-11 |
13D
|
KNTE / Kinnate Biopharma Inc.
|
|
6,589,330 |
3,397,929 |
|
|
|
| 2020-12-11 |
13D
|
SBTX / Silverback Therapeutics Inc
|
|
|
7,788,511 |
|
|
|
| 2020-11-20 |
13D/A
|
KROS / Keros Therapeutics, Inc.
|
|
1,268,734 |
1,268,734 |
|
|
|
| 2020-11-18 |
13D/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,765,717 |
2,765,717 |
|
|
|
| 2020-11-12 |
13D/A
|
AADI / Aadi Bioscience, Inc.
|
|
5,193,946 |
5,193,946 |
|
|
|
| 2020-11-06 |
13D
|
GLTO / Galecto, Inc.
|
|
|
2,771,444 |
|
|
|
| 2020-10-23 |
13D/A
|
BLU / Bellus Health Inc
|
|
3,954,800 |
3,954,800 |
|
|
|
| 2020-10-14 |
13D/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
7,406,307 |
7,406,307 |
|
|
|
| 2020-10-07 |
13D/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
4,067,564 |
4,267,564 |
|
|
|
| 2020-10-06 |
13D/A
|
LOGC / ContextLogic Holdings Inc.
|
|
|
4,126,972 |
|
|
|
| 2020-10-05 |
13D
|
GRAY / Graybug Vision Inc
|
|
|
4,163,347 |
|
|
|
| 2020-10-05 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
14,014,321 |
72,810,381 |
|
|
|
| 2020-10-05 |
13D
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
6,589,330 |
|
|
|
| 2020-10-05 |
13D
|
PRLD / Prelude Therapeutics Incorporated
|
|
|
14,805,377 |
|
|
|
| 2020-09-23 |
13D/A
|
ETNB / 89bio, Inc.
|
|
2,002,221 |
1,864,721 |
|
|
|
| 2020-09-18 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
4,830,387 |
5,513,015 |
|
|
|
| 2020-08-19 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
1,471,853 |
1,177,483 |
|
|
|
| 2020-08-18 |
13D
|
AFIB / Acutus Medical, Inc.
|
|
|
5,810,525 |
|
|
|
| 2020-07-30 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,816,206 |
3,816,206 |
|
|
|
| 2020-07-28 |
13G
|
/ Pandion Therapeutics Inc
|
|
|
1,040,825 |
|
|
|
| 2020-07-16 |
13D/A
|
ALEC / Alector, Inc.
|
|
5,502,048 |
2,725,313 |
|
|
|
| 2020-07-13 |
13D/A
|
ETNB / 89bio, Inc.
|
|
2,002,221 |
2,002,221 |
|
|
|
| 2020-07-10 |
13D/A
|
ALEC / Alector, Inc.
|
|
6,466,992 |
5,502,048 |
|
|
|
| 2020-07-01 |
13D/A
|
TELA / TELA Bio, Inc.
|
|
3,058,267 |
3,058,267 |
|
|
|
| 2020-06-26 |
13D
|
RPTX / Repare Therapeutics Inc.
|
|
|
3,276,325 |
|
|
|
| 2020-06-11 |
13D/A
|
BLU / Bellus Health Inc
|
|
|
3,954,800 |
|
|
|
| 2020-06-04 |
13D/A
|
ALEC / Alector, Inc.
|
|
7,862,392 |
6,466,992 |
|
|
|
| 2020-05-26 |
13D/A
|
SCPH / scPharmaceuticals Inc.
|
|
3,409,865 |
4,797,148 |
|
|
|
| 2020-05-22 |
13D/A
|
TPTX / Turning Point Therapeutics Inc
|
|
2,027,550 |
2,027,550 |
|
|
|
| 2020-05-22 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,518,782 |
2,083,713 |
|
|
|
| 2020-05-20 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
11,614,321 |
14,014,321 |
|
|
|
| 2020-05-08 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,011,900 |
2,518,782 |
|
|
|
| 2020-05-01 |
13D
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
2,765,717 |
|
|
|
| 2020-04-17 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
6,624,928 |
6,767,584 |
|
|
|
| 2020-04-17 |
13D
|
KROS / Keros Therapeutics, Inc.
|
|
|
1,268,734 |
|
|
|
| 2020-04-17 |
13D/A
|
ALEC / Alector, Inc.
|
|
8,716,344 |
7,862,392 |
|
|
|
| 2020-03-27 |
13D/A
|
SCPH / scPharmaceuticals Inc.
|
|
3,409,865 |
3,409,865 |
|
|
|
| 2020-03-20 |
13D
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
|
2,532,402 |
|
|
|
| 2020-03-10 |
13G/A
|
CTIC / CTI BioPharma Corp
|
|
5,000,000 |
9,520,000 |
|
|
|
| 2020-03-09 |
13D
|
PASG / Passage Bio, Inc.
|
|
|
5,947,323 |
|
|
|
| 2020-03-05 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,397,673 |
3,011,900 |
|
|
|
| 2020-03-04 |
13D/A
|
ALEC / Alector, Inc.
|
|
10,551,739 |
8,716,344 |
|
|
|
| 2020-02-18 |
13G
|
KRYS / Krystal Biotech, Inc.
|
|
933,508 |
933,508 |
|
|
|
| 2020-02-14 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
2,063,837 |
0 |
|
|
|
| 2020-02-14 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
2,299,900 |
0 |
|
|
|
| 2020-02-14 |
13G
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
3,944,090 |
|
|
|
| 2020-02-14 |
13G
|
PRTA / Prothena Corporation plc
|
|
0 |
2,288,439 |
|
|
|
| 2020-02-14 |
13G/A
|
INSP / Inspire Medical Systems, Inc.
|
|
1,829,449 |
1,347,000 |
|
|
|
| 2020-02-14 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
2,165,524 |
2,865,524 |
|
|
|
| 2020-02-14 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
1,914,282 |
2,039,282 |
|
|
|
| 2020-02-14 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,100,000 |
977,714 |
|
|
|
| 2020-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
2,093,900 |
1,256,371 |
|
|
|
| 2020-02-14 |
13G
|
APLT / Applied Therapeutics, Inc.
|
|
|
849,254 |
|
|
|
| 2020-02-14 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
|
988,800 |
|
|
|
| 2020-02-14 |
13G
|
MGTX / MeiraGTx Holdings plc
|
|
|
3,448,820 |
|
|
|
| 2020-02-14 |
13G
|
KRYS / Krystal Biotech, Inc.
|
|
|
933,508 |
|
|
|
| 2020-02-10 |
13D
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
4,067,564 |
|
|
|
| 2020-02-05 |
13D/A
|
SELB / Selecta Biosciences Inc
|
|
2,879,064 |
2,779,064 |
|
|
|
| 2020-02-05 |
13D/A
|
ALEC / Alector, Inc.
|
|
10,551,739 |
10,551,739 |
|
|
|
| 2020-01-13 |
13D/A
|
ALEC / Alector, Inc.
|
|
11,392,229 |
10,551,739 |
|
|
|
| 2019-12-26 |
13D/A
|
NBRV / Nabriva Therapeutics Plc
|
|
4,644,600 |
4,644,600 |
|
|
|
| 2019-12-19 |
13D/A
|
ALEC / Alector, Inc.
|
|
12,240,829 |
11,392,229 |
|
|
|
| 2019-12-13 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
2,634,336 |
288,119 |
|
|
|
| 2019-12-12 |
13D/A
|
TCDA / Tricida Inc
|
|
11,114,280 |
9,617,912 |
|
|
|
| 2019-12-06 |
13D/A
|
NBRV / Nabriva Therapeutics Plc
|
|
4,644,600 |
4,644,600 |
|
|
|
| 2019-11-27 |
13D
|
SRRA / Sierra Oncology Inc
|
|
417,104 |
18,660,402 |
|
|
|
| 2019-11-25 |
13D
|
ETNB / 89bio, Inc.
|
|
|
2,002,221 |
|
|
|
| 2019-11-25 |
13D
|
TELA / TELA Bio, Inc.
|
|
|
3,058,267 |
|
|
|
| 2019-11-19 |
13D/A
|
NXTC / NextCure, Inc.
|
|
2,711,013 |
2,711,013 |
|
|
|
| 2019-11-13 |
13D/A
|
SELB / Selecta Biosciences Inc
|
|
1,579,064 |
2,879,064 |
|
|
|
| 2019-11-12 |
13G
|
EPIX / ESSA Pharma Inc.
|
|
|
1,471,853 |
|
|
|
| 2019-09-25 |
13D
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
7,406,307 |
|
|
|
| 2019-09-18 |
13D
|
BLUSF / BELLUS Health Inc.
|
|
|
4,943,416 |
|
|
|
| 2019-09-09 |
13D/A
|
AVDR / New Age Alpha Trust - AVDR US LargeCap Leading ETF
|
|
4,346,745 |
4,346,745 |
|
|
|
| 2019-08-14 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,633,373 |
3,397,673 |
|
|
|
| 2019-08-13 |
13D/A
|
VRAY / ViewRay Inc.
|
|
5,556,554 |
407,535 |
|
|
|
| 2019-08-12 |
13D/A
|
ALEC / Alector, Inc.
|
|
12,240,829 |
12,240,829 |
|
|
|
| 2019-08-12 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
2,029,996 |
2,029,996 |
|
|
|
| 2019-08-09 |
13D/A
|
ALEC / Alector, Inc.
|
|
12,890,829 |
12,240,829 |
|
|
|
| 2019-07-02 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
5,967,584 |
6,624,928 |
|
|
|
| 2019-06-27 |
13D
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
|
13,822,463 |
|
|
|
| 2019-05-21 |
13D
|
NXTC / NextCure, Inc.
|
|
|
2,711,013 |
|
|
|
| 2019-04-24 |
13D
|
TPTX / Turning Point Therapeutics Inc
|
|
|
2,027,550 |
|
|
|
| 2019-04-19 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
311,493 |
1,248,993 |
|
|
|
| 2019-04-09 |
13D/A
|
TCDA / Tricida Inc
|
|
10,889,280 |
11,114,280 |
|
|
|
| 2019-04-04 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
10,414,321 |
11,614,321 |
|
|
|
| 2019-03-25 |
13D/A
|
ACET / Adicet Bio, Inc.
|
|
|
4,830,387 |
|
|
|
| 2019-03-19 |
13D/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
311,493 |
|
|
|
| 2019-03-12 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,763,291 |
3,633,373 |
|
|
|
| 2019-03-01 |
13D/A
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
10,425,225 |
10,425,225 |
|
|
|
| 2019-02-28 |
13D
|
AVDR / New Age Alpha Trust - AVDR US LargeCap Leading ETF
|
|
|
4,346,745 |
|
|
|
| 2019-02-21 |
13G
|
HARP / Harpoon Therapeutics, Inc.
|
|
|
1,360,704 |
|
|
|
| 2019-02-20 |
13D
|
ALEC / Alector, Inc.
|
|
|
12,890,829 |
|
|
|
| 2019-02-13 |
13G
|
INSP / Inspire Medical Systems, Inc.
|
|
1,829,449 |
1,829,449 |
|
|
|
| 2019-02-13 |
13G
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
2,093,900 |
2,093,900 |
|
|
|
| 2019-02-13 |
13G
|
CLVS / Clovis Oncology Inc
|
|
2,299,900 |
2,299,900 |
|
|
|
| 2019-02-13 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
417,104 |
417,104 |
|
|
|
| 2019-02-13 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
2,063,837 |
2,063,837 |
|
|
|
| 2019-02-13 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
3,447,840 |
3,447,840 |
|
|
|
| 2019-02-13 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
4,210,526 |
4,210,526 |
|
|
|
| 2019-02-13 |
13G/A
|
INSY / Insys Therapeutics Inc.
|
|
0 |
0 |
|
|
|
| 2019-02-13 |
13G/A
|
/ Immunomedics, Inc.
|
|
4,089,500 |
4,089,500 |
|
|
|
| 2019-02-13 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
0 |
0 |
|
|
|
| 2019-02-13 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,100,000 |
1,100,000 |
|
|
|
| 2019-02-13 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
1,893,500 |
1,893,500 |
|
|
|
| 2019-02-13 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
996,123 |
996,123 |
|
|
|
| 2019-02-13 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
2,165,524 |
2,165,524 |
|
|
|
| 2019-02-13 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
0 |
0 |
|
|
|
| 2019-02-13 |
13G/A
|
98235T107 / Wright Medical Group N.V.
|
|
3,816,250 |
3,816,250 |
|
|
|
| 2019-02-12 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
4,936,173 |
0 |
|
|
|
| 2019-02-12 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
1,469,524 |
2,165,524 |
|
|
|
| 2019-02-12 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
625,300 |
996,123 |
|
|
|
| 2019-02-12 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
4,129,638 |
1,893,500 |
|
|
|
| 2019-02-12 |
13G
|
CLVS / Clovis Oncology Inc
|
|
|
2,299,900 |
|
|
|
| 2019-02-12 |
13G
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
2,093,900 |
|
|
|
| 2019-02-12 |
13G/A
|
EHTH / eHealth, Inc.
|
|
991,500 |
1,100,000 |
|
|
|
| 2019-02-12 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
1,467,120 |
0 |
|
|
|
| 2019-02-12 |
13G/A
|
/ Immunomedics, Inc.
|
|
5,019,776 |
4,089,500 |
|
|
|
| 2019-02-12 |
13G
|
INSP / Inspire Medical Systems, Inc.
|
|
|
1,829,449 |
|
|
|
| 2019-02-12 |
13G/A
|
INSY / Insys Therapeutics Inc.
|
|
2,914,000 |
0 |
|
|
|
| 2019-02-12 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
3,246,226 |
4,210,526 |
|
|
|
| 2019-02-12 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
2,692,715 |
3,447,840 |
|
|
|
| 2019-02-12 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
1,238,846 |
2,063,837 |
|
|
|
| 2019-02-12 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
3,203,704 |
417,104 |
|
|
|
| 2019-02-12 |
13G/A
|
98235T107 / Wright Medical Group N.V.
|
|
4,074,064 |
3,816,250 |
|
|
|
| 2019-01-23 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,298,516 |
3,816,206 |
|
|
|
| 2018-11-13 |
13D/A
|
VRAY / ViewRay Inc.
|
|
6,515,891 |
5,556,554 |
|
|
|
| 2018-11-05 |
13D/A
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
10,425,225 |
10,425,225 |
|
|
|
| 2018-10-25 |
13D/A
|
SELB / Selecta Biosciences Inc
|
|
1,849,371 |
1,579,064 |
|
|
|
| 2018-10-10 |
13G
|
ARVN / Arvinas, Inc.
|
|
|
1,916,310 |
|
|
|
| 2018-10-10 |
13D/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
30,607,860 |
29,407,858 |
|
|
|
| 2018-09-27 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
3,140,000 |
2,455,900 |
|
|
|
| 2018-09-27 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
2,634,336 |
|
|
|
| 2018-09-19 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
9,214,321 |
10,414,321 |
|
|
|
| 2018-09-07 |
13D/A
|
STDY / SteadyMed Ltd.
|
|
3,952,696 |
0 |
|
|
|
| 2018-08-31 |
13D/A
|
VRAY / ViewRay Inc.
|
|
7,711,409 |
6,515,891 |
|
|
|
| 2018-08-21 |
13D/A
|
VRAY / ViewRay Inc.
|
|
8,418,964 |
7,711,409 |
|
|
|
| 2018-08-15 |
13D
|
RLM / Realm Therapeutics plc
|
|
|
35,751,953 |
|
|
|
| 2018-08-13 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
8,418,964 |
|
|
|
| 2018-08-10 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,065,000 |
1,629,700 |
|
|
|
| 2018-08-02 |
13D/A
|
NBRV / Nabriva Therapeutics Plc
|
|
3,919,600 |
4,644,600 |
|
|
|
| 2018-07-30 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
1,914,282 |
|
|
|
| 2018-07-11 |
13D
|
TCDA / Tricida Inc
|
|
|
10,889,280 |
|
|
|
| 2018-07-02 |
13D/A
|
AADI / Aadi Bioscience, Inc.
|
|
|
5,193,946 |
|
|
|
| 2018-06-27 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,375,000 |
2,065,000 |
|
|
|
| 2018-06-22 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
3,950,000 |
3,140,000 |
|
|
|
| 2018-06-15 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,374,391 |
3,763,291 |
|
|
|
| 2018-06-04 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,901,295 |
2,375,000 |
|
|
|
| 2018-05-29 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
4,550,000 |
3,950,000 |
|
|
|
| 2018-05-02 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,550,000 |
4,550,000 |
|
|
|
| 2018-05-01 |
13D/A
|
STDY / SteadyMed Ltd.
|
|
3,952,696 |
3,952,696 |
|
|
|
| 2018-04-12 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
2,029,996 |
2,029,996 |
|
|
|
| 2018-03-29 |
13D/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
36,896,260 |
30,607,860 |
|
|
|
| 2018-03-14 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
5,379,349 |
5,967,584 |
|
|
|
| 2018-03-06 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
9,866,102 |
|
|
|
| 2018-02-21 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,550,000 |
5,550,000 |
|
|
|
| 2018-02-16 |
13D/A
|
NTLA / Intellia Therapeutics, Inc.
|
|
2,537,684 |
2,113,000 |
|
|
|
| 2018-02-15 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
2,838,903 |
9,214,321 |
|
|
|
| 2018-02-13 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
8,834,147 |
1,515,572 |
|
|
|
| 2018-02-13 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
3,250,300 |
0 |
|
|
|
| 2018-02-13 |
13G/A
|
INSM / Insmed Incorporated
|
|
5,301,805 |
859,700 |
|
|
|
| 2018-02-13 |
13G/A
|
/ Immunomedics, Inc.
|
|
9,677,008 |
5,019,776 |
|
|
|
| 2018-02-13 |
13G/A
|
INSY / Insys Therapeutics Inc.
|
|
6,071,440 |
2,914,000 |
|
|
|
| 2018-02-13 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
5,656,626 |
3,246,226 |
|
|
|
| 2018-02-13 |
13G/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
2,788,111 |
474,052 |
|
|
|
| 2018-02-13 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
1,991,700 |
0 |
|
|
|
| 2018-02-13 |
13G/A
|
OBSV / ObsEva SA.
|
|
2,559,931 |
2,605,531 |
|
|
|
| 2018-02-13 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
2,275,825 |
1,238,846 |
|
|
|
| 2018-02-13 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
2,305,446 |
662,287 |
|
|
|
| 2018-02-13 |
13G/A
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
18,241,398 |
0 |
|
|
|
| 2018-02-13 |
13G
|
SRRA / Sierra Oncology Inc
|
|
0 |
3,203,704 |
|
|
|
| 2018-02-13 |
13G/A
|
98235T107 / Wright Medical Group N.V.
|
|
7,584,334 |
4,074,064 |
|
|
|
| 2018-02-13 |
13G/A
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
634,812 |
|
|
|
| 2018-02-13 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
13,107,200 |
4,936,173 |
|
|
|
| 2018-02-13 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
1,360,224 |
1,469,524 |
|
|
|
| 2018-02-13 |
13G/A
|
/ Array BioPharma, Inc.
|
|
16,088,800 |
4,299,200 |
|
|
|
| 2018-02-13 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
1,397,100 |
625,300 |
|
|
|
| 2018-02-13 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
|
4,129,638 |
|
|
|
| 2018-02-13 |
13G/A
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
1,826,500 |
645,000 |
|
|
|
| 2018-02-13 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,820,000 |
991,500 |
|
|
|
| 2018-02-13 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
2,056,861 |
1,467,120 |
|
|
|
| 2018-02-13 |
13G/A
|
GKOS / Glaukos Corporation
|
|
2,180,000 |
836,500 |
|
|
|
| 2018-02-08 |
13D
|
ARMO / ARMO BioSciences, Inc.
|
|
|
4,118,903 |
|
|
|
| 2018-02-07 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
2,901,295 |
|
|
|
| 2018-02-02 |
13D
|
ACET / Adicet Bio, Inc.
|
|
|
4,830,387 |
|
|
|
| 2018-01-29 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,568,291 |
4,374,391 |
|
|
|
| 2018-01-29 |
13D/A
|
NTLA / Intellia Therapeutics, Inc.
|
|
2,537,684 |
2,537,684 |
|
|
|
| 2018-01-26 |
13D/A
|
SCPH / scPharmaceuticals Inc.
|
|
|
3,409,865 |
|
|
|
| 2018-01-26 |
13D/A
|
SYBX / Synlogic, Inc.
|
|
1,314,996 |
2,029,996 |
|
|
|
| 2018-01-26 |
13D/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
11,871,112 |
|
|
|
| 2018-01-26 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
571,428 |
571,428 |
|
|
|
| 2018-01-26 |
13D/A
|
STDY / SteadyMed Ltd.
|
|
3,952,696 |
3,952,696 |
|
|
|
| 2018-01-26 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
9,866,102 |
|
|
|
| 2018-01-26 |
13D/A
|
SELB / Selecta Biosciences Inc
|
|
1,849,371 |
1,849,371 |
|
|
|
| 2018-01-26 |
13D/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
28,041,004 |
36,896,260 |
|
|
|
| 2018-01-26 |
13D/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
5,258,450 |
5,379,349 |
|
|
|
| 2018-01-26 |
13D/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,868,966 |
1,868,966 |
|
|
|
| 2018-01-26 |
13D/A
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
|
10,425,225 |
|
|
|
| 2018-01-26 |
13D/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
3,298,516 |
|
|
|
| 2018-01-26 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
5,550,000 |
5,550,000 |
|
|
|
| 2018-01-26 |
13D/A
|
NBRV / Nabriva Therapeutics Plc
|
|
307,179 |
3,919,600 |
|
|
|
| 2018-01-17 |
13D/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
1,952,670 |
2,838,903 |
|
|
|
| 2018-01-12 |
13G
|
KALA / KALA BIO, Inc.
|
|
|
2,692,715 |
|
|
|
| 2018-01-05 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
7,259,620 |
5,550,000 |
|
|
|
| 2017-12-01 |
13D
|
SCPH / scPharmaceuticals Inc.
|
|
|
3,409,865 |
|
|
|
| 2017-11-30 |
13D
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
1,868,966 |
|
|
|
| 2017-11-20 |
13D/A
|
LOXO / Loxo Oncology, Inc.
|
|
1,728,000 |
1,458,000 |
|
|
|
| 2017-11-08 |
13D/A
|
NTLA / Intellia Therapeutics, Inc.
|
|
2,662,180 |
2,537,684 |
|
|
|
| 2017-10-27 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
9,866,102 |
|
|
|
| 2017-10-20 |
13D
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
2,901,295 |
|
|
|
| 2017-10-05 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
773,045 |
571,428 |
|
|
|
| 2017-10-02 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
1,247,721 |
773,045 |
|
|
|
| 2017-09-28 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
1,389,622 |
1,247,721 |
|
|
|
| 2017-09-07 |
13D
|
SYBX / Synlogic, Inc.
|
|
|
1,314,996 |
|
|
|
| 2017-08-23 |
13D/A
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
|
10,425,225 |
|
|
|
| 2017-08-23 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
1,464,898 |
1,389,622 |
|
|
|
| 2017-08-15 |
13D/A
|
SELB / Selecta Biosciences Inc
|
|
1,842,797 |
1,849,371 |
|
|
|
| 2017-08-11 |
13D
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
|
10,425,225 |
|
|
|
| 2017-08-09 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
9,866,102 |
|
|
|
| 2017-08-03 |
13D
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
3,298,516 |
|
|
|
| 2017-08-03 |
13D
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
3,298,516 |
|
|
|
| 2017-07-06 |
13D/A
|
OTIC / Otonomy Inc
|
|
1,850,094 |
1,397,567 |
|
|
|
| 2017-06-21 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,198,291 |
4,568,291 |
|
|
|
| 2017-06-15 |
13G
|
CTIC / CTI BioPharma Corp
|
|
|
5,000,000 |
|
|
|
| 2017-06-15 |
13G
|
CTIC / CTI BioPharma Corp
|
|
|
5,000,000 |
|
|
|
| 2017-05-30 |
13D
|
XTNT / Xtant Medical Holdings, Inc.
|
|
1,862,030 |
1,952,670 |
|
|
|
| 2017-05-08 |
13D
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
11,871,112 |
|
|
|
| 2017-05-08 |
13D
|
VNAPF / Verona Pharma Plc
|
|
|
11,871,112 |
|
|
|
| 2017-04-28 |
13D/A
|
STDY / SteadyMed Ltd.
|
|
3,072,196 |
3,952,696 |
|
|
|
| 2017-03-27 |
13D
|
AADI / Aadi Bioscience, Inc.
|
|
|
4,416,446 |
|
|
|
| 2017-03-21 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,866,102 |
9,866,102 |
|
|
|
| 2017-03-06 |
13D/A
|
AFMD / Affimed N.V.
|
|
3,055,000 |
2,020,000 |
|
|
|
| 2017-02-13 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
1,989,949 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
1,267,076 |
1,862,030 |
|
|
|
| 2017-02-13 |
13G
|
LUMO / Lumos Pharma, Inc.
|
|
|
1,991,700 |
|
|
|
| 2017-02-13 |
13G/A
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
15,138,384 |
18,241,398 |
|
|
|
| 2017-02-13 |
13G/A
|
SIEN / Sientra, Inc.
|
|
1,357,500 |
742,574 |
|
|
|
| 2017-02-13 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
5,768,400 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
6,095,647 |
8,834,147 |
|
|
|
| 2017-02-13 |
13G/A
|
/ Immunomedics, Inc.
|
|
9,677,008 |
9,677,008 |
|
|
|
| 2017-02-13 |
13G
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
2,788,111 |
|
|
|
| 2017-02-13 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
5,656,626 |
|
|
|
| 2017-02-13 |
13G
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
1,826,500 |
|
|
|
| 2017-02-13 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
2,628,650 |
2,056,861 |
|
|
|
| 2017-02-13 |
13G/A
|
GKOS / Glaukos Corporation
|
|
2,897,937 |
2,180,000 |
|
|
|
| 2017-02-13 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
2,271,500 |
2,305,446 |
|
|
|
| 2017-02-13 |
13G/A
|
98235T107 / Wright Medical Group N.V.
|
|
8,245,111 |
7,584,334 |
|
|
|
| 2017-02-13 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
11,226,400 |
7,241,300 |
|
|
|
| 2017-02-13 |
13G/A
|
MGLN / Magellan Health Inc
|
|
1,833,000 |
801,600 |
|
|
|
| 2017-02-13 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
2,011,500 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
2,238,825 |
2,275,825 |
|
|
|
| 2017-02-13 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,300,000 |
1,820,000 |
|
|
|
| 2017-02-13 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
4,416,300 |
3,250,300 |
|
|
|
| 2017-02-13 |
13G/A
|
INSM / Insmed Incorporated
|
|
3,469,900 |
5,301,805 |
|
|
|
| 2017-02-13 |
13G/A
|
INSY / Insys Therapeutics Inc.
|
|
4,366,740 |
6,071,440 |
|
|
|
| 2017-02-13 |
13G/A
|
IPXL / Impax Laboratories, Inc.
|
|
6,664,100 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
CNXR / Connecture, Inc.
|
|
1,740,000 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
2,472,200 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
9,649,900 |
13,107,200 |
|
|
|
| 2017-02-13 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
7,511,000 |
0 |
|
|
|
| 2017-02-13 |
13G/A
|
/ Array BioPharma, Inc.
|
|
10,689,000 |
16,088,800 |
|
|
|
| 2017-02-13 |
13G/A
|
CERS / Cerus Corporation
|
|
6,504,400 |
0 |
|
|
|
| 2017-02-07 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
1,464,671 |
1,464,898 |
|
|
|
| 2017-02-03 |
13G
|
OBSV / ObsEva SA.
|
|
|
2,559,931 |
|
|
|
| 2017-01-27 |
13D/A
|
AFMD / Affimed N.V.
|
|
3,375,000 |
3,055,000 |
|
|
|
| 2017-01-20 |
13D/A
|
VRAY / ViewRay Inc.
|
|
9,469,411 |
9,866,102 |
|
|
|
| 2017-01-12 |
13D/A
|
LOXO / Loxo Oncology, Inc.
|
|
1,728,000 |
1,728,000 |
|
|
|
| 2016-12-08 |
13G/A
|
CYNA / Cynapsus Therapeutics Inc.
|
|
816,154 |
0 |
|
|
|
| 2016-12-01 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
6,000,328 |
0 |
|
|
|
| 2016-12-01 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
6,000,328 |
0 |
|
|
|
| 2016-11-14 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
14,873,637 |
1,464,671 |
|
|
|
| 2016-10-24 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,671,976 |
4,198,291 |
|
|
|
| 2016-09-26 |
13D/A
|
AFMD / Affimed N.V.
|
|
4,053,000 |
3,375,000 |
|
|
|
| 2016-09-23 |
13D/A
|
ROKA / Roka Bioscience, Inc.
|
|
|
14,873,637 |
|
|
|
| 2016-09-16 |
13G/A
|
CYNA / Cynapsus Therapeutics Inc.
|
|
1,620,325 |
816,154 |
|
|
|
| 2016-08-26 |
13D
|
VRAY / ViewRay Inc.
|
|
|
9,469,411 |
|
|
|
| 2016-08-12 |
13D
|
STDY / SteadyMed Ltd.
|
|
|
3,072,196 |
|
|
|
| 2016-08-12 |
13D/A
|
LOXO / Loxo Oncology, Inc.
|
|
2,175,857 |
1,728,000 |
|
|
|
| 2016-08-05 |
13D/A
|
LOXO / Loxo Oncology, Inc.
|
|
2,175,857 |
2,175,857 |
|
|
|
| 2016-07-28 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
3,356,400 |
0 |
|
|
|
| 2016-07-26 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
7,400,000 |
3,356,400 |
|
|
|
| 2016-07-12 |
13D/A
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
7,259,620 |
7,259,620 |
|
|
|
| 2016-07-08 |
13G/A
|
CYNA / Cynapsus Therapeutics Inc.
|
|
1,227,353 |
1,620,325 |
|
|
|
| 2016-07-07 |
13D
|
SELB / Selecta Biosciences Inc
|
|
|
1,842,797 |
|
|
|
| 2016-06-30 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,300,462 |
3,671,976 |
|
|
|
| 2016-06-21 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,000,462 |
3,300,462 |
|
|
|
| 2016-06-20 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
|
6,000,328 |
|
|
|
| 2016-06-20 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
|
6,000,328 |
|
|
|
| 2016-06-17 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,492,199 |
3,000,462 |
|
|
|
| 2016-06-09 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,067,199 |
2,492,199 |
|
|
|
| 2016-06-07 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
1,703,199 |
2,067,199 |
|
|
|
| 2016-06-03 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
7,400,000 |
7,400,000 |
|
|
|
| 2016-05-20 |
13D
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
2,662,180 |
|
|
|
| 2016-04-18 |
13G
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
1,360,224 |
|
|
|
| 2016-04-13 |
13G/A
|
09074D103 / Biotie Therapies Corp.
|
|
125,382,648 |
0 |
|
|
|
| 2016-04-01 |
13D
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
5,258,450 |
5,258,450 |
|
|
|
| 2016-03-31 |
13D/A
|
AFMD / Affimed N.V.
|
|
4,500,641 |
4,053,000 |
|
|
|
| 2016-03-17 |
13D/A
|
AFMD / Affimed N.V.
|
|
4,582,616 |
4,500,641 |
|
|
|
| 2016-03-16 |
13D/A
|
OTIC / Otonomy Inc
|
|
1,917,200 |
1,850,094 |
|
|
|
| 2016-02-16 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
11,226,400 |
|
|
|
| 2016-02-16 |
13G/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
|
1,267,076 |
|
|
|
| 2016-02-16 |
13G/A
|
CYNA / Cynapsus Therapeutics Inc.
|
|
1,216,687 |
1,227,353 |
|
|
|
| 2016-02-16 |
13G
|
/ Immunomedics, Inc.
|
|
|
9,677,008 |
|
|
|
| 2016-02-16 |
13G/A
|
VSCI /
|
|
|
990,745 |
|
|
|
| 2016-02-16 |
13G/A
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
14,857,736 |
15,138,384 |
|
|
|
| 2016-02-16 |
13G
|
EHTH / eHealth, Inc.
|
|
|
1,300,000 |
|
|
|
| 2016-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
0 |
1,133,592 |
|
|
|
| 2016-02-16 |
13G
|
SRRA / Sierra Oncology Inc
|
|
|
1,989,949 |
|
|
|
| 2016-02-16 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
|
2,628,650 |
|
|
|
| 2016-02-16 |
13G
|
DVAX / Dynavax Technologies Corporation
|
|
|
2,472,200 |
|
|
|
| 2016-02-12 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
10,689,000 |
|
|
|
| 2016-02-12 |
13G
|
INSM / Insmed Incorporated
|
|
|
3,469,900 |
|
|
|
| 2016-02-12 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
4,416,300 |
|
|
|
| 2016-02-12 |
13G
|
GKOS / Glaukos Corporation
|
|
|
2,897,937 |
|
|
|
| 2016-02-12 |
13G
|
CNXR / Connecture, Inc.
|
|
|
1,740,000 |
|
|
|
| 2016-02-12 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,397,100 |
|
|
|
| 2016-02-12 |
13G
|
INSY / Insys Therapeutics Inc.
|
|
|
4,366,740 |
|
|
|
| 2016-02-12 |
13G
|
IMGN / ImmunoGen, Inc.
|
|
|
6,095,647 |
|
|
|
| 2016-02-12 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
|
7,511,000 |
|
|
|
| 2016-02-12 |
13G
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
9,649,900 |
|
|
|
| 2016-02-12 |
13G/A
|
CERS / Cerus Corporation
|
|
|
6,504,400 |
|
|
|
| 2016-02-12 |
13G/A
|
ARQL / ArQule, Inc.
|
|
0 |
0 |
|
|
|
| 2016-02-12 |
13G/A
|
IPXL / Impax Laboratories, Inc.
|
|
|
6,664,100 |
|
|
|
| 2016-02-11 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
|
2,271,500 |
|
|
|
| 2016-02-11 |
13G
|
MGLN / Magellan Health Inc
|
|
|
1,833,000 |
|
|
|
| 2016-02-11 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
2,514,974 |
|
|
|
| 2016-02-11 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
376,999 |
|
|
|
| 2016-02-11 |
13G/A
|
SIEN / Sientra, Inc.
|
|
|
1,357,500 |
|
|
|
| 2016-02-11 |
13G/A
|
98235T107 / Wright Medical Group N.V.
|
|
|
8,245,111 |
|
|
|
| 2016-02-11 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
0 |
0 |
|
|
|
| 2016-02-11 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
2,011,500 |
|
|
|
| 2016-02-11 |
13G
|
PBYI / Puma Biotechnology, Inc.
|
|
|
2,238,825 |
|
|
|
| 2016-02-11 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
|
0 |
|
|
|
| 2016-02-11 |
13G/A
|
MOH / Molina Healthcare, Inc.
|
|
|
568,850 |
|
|
|
| 2016-02-11 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
|
5,768,400 |
|
|
|
| 2016-02-11 |
13G/A
|
SVA / Sinovac Biotech, Ltd.
|
|
|
2,667,500 |
|
|
|
| 2015-12-24 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
7,900,000 |
7,400,000 |
|
|
|
| 2015-11-25 |
13D/A
|
OTIC / Otonomy Inc
|
|
|
1,917,200 |
|
|
|
| 2015-11-20 |
13D/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
26,467,120 |
1,703,199 |
|
|
|
| 2015-11-19 |
13D/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
28,041,004 |
|
|
|
| 2015-11-19 |
13D/A
|
LOXO / Loxo Oncology, Inc.
|
|
|
2,175,857 |
|
|
|
| 2015-11-06 |
13D
|
DMTX / Dimension Therapeutics, Inc.
|
|
|
5,397,698 |
|
|
|
| 2015-10-30 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
7,400,000 |
7,900,000 |
|
|
|
| 2015-10-02 |
13D
|
NBRV / Nabriva Therapeutics Plc
|
|
|
307,179 |
|
|
|
| 2015-09-04 |
13G/A
|
09074D103 / Biotie Therapies Corp.
|
|
73,438,204 |
125,382,648 |
|
|
|
| 2015-08-17 |
13D/A
|
AFMD / Affimed N.V.
|
|
5,814,630 |
4,582,616 |
|
|
|
| 2015-07-09 |
13D
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
7,259,620 |
|
|
|
| 2015-07-02 |
13G
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
1,216,687 |
|
|
|
| 2015-06-26 |
13G
|
09074D103 / Biotie Therapies Corp.
|
|
|
73,438,204 |
|
|
|
| 2015-05-20 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
8,857,551 |
7,400,000 |
|
|
|
| 2015-05-15 |
13D
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
26,467,120 |
|
|
|
| 2015-05-14 |
13D/A
|
AFMD / Affimed N.V.
|
|
|
5,814,630 |
|
|
|
| 2015-03-30 |
13D/A
|
ICPT / Intercept Pharmaceuticals Inc
|
|
1,277,524 |
1,120,324 |
|
|
|
| 2015-03-25 |
13D/A
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
1,277,524 |
|
|
|
| 2015-03-09 |
13G
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
14,857,736 |
|
|
|
| 2015-03-06 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
|
8,857,551 |
|
|
|
| 2015-02-20 |
13D/A
|
AFMD / Affimed N.V.
|
|
|
5,814,630 |
|
|
|
| 2015-02-17 |
13G
|
PRQR / ProQR Therapeutics N.V.
|
|
|
1,829,400 |
|
|
|
| 2015-02-17 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
|
6,568,000 |
|
|
|
| 2015-02-17 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
1,511,799 |
|
|
|
| 2015-02-17 |
13G
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
5,968,600 |
|
|
|
| 2015-02-17 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,343,292 |
|
|
|
| 2015-02-17 |
13G/A
|
EXAS / Exact Sciences Corporation
|
|
|
1,778,000 |
|
|
|
| 2015-02-17 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
|
2,136,200 |
|
|
|
| 2015-02-17 |
13G/A
|
OSUR / OraSure Technologies, Inc.
|
|
|
1,978,500 |
|
|
|
| 2015-02-17 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
|
2,205,100 |
|
|
|
| 2015-02-17 |
13G/A
|
PODD / Insulet Corporation
|
|
|
1,997,000 |
|
|
|
| 2015-02-17 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
1,073,000 |
|
|
|
| 2015-02-17 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
|
0 |
|
|
|
| 2015-02-17 |
13G/A
|
UPI / Uroplasty Inc
|
|
|
1,363,500 |
|
|
|
| 2015-02-17 |
13G
|
SIEN / Sientra, Inc.
|
|
|
3,185,308 |
|
|
|
| 2015-02-17 |
13G
|
WMGIZ / Wright Medical Group N.V.
|
|
|
4,805,000 |
|
|
|
| 2015-02-17 |
13G/A
|
XLRN / Acceleron Pharma Inc
|
|
|
0 |
|
|
|
| 2015-02-17 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
|
5,546,100 |
|
|
|
| 2015-02-17 |
13G
|
/ Array BioPharma, Inc.
|
|
|
7,247,700 |
|
|
|
| 2015-02-17 |
13G
|
CERS / Cerus Corporation
|
|
|
7,035,000 |
|
|
|
| 2015-02-17 |
13G
|
SVA / Sinovac Biotech, Ltd.
|
|
|
2,821,500 |
|
|
|
| 2015-02-17 |
13G
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
12,012,100 |
|
|
|
| 2015-02-17 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
4,736,900 |
|
|
|
| 2015-02-17 |
13G/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
|
563,158 |
|
|
|
| 2015-02-17 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
|
2,424,500 |
|
|
|
| 2015-02-17 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
| 2015-02-17 |
13G
|
MOH / Molina Healthcare, Inc.
|
|
|
3,581,900 |
|
|
|
| 2015-02-17 |
13G/A
|
IPXL / Impax Laboratories, Inc.
|
|
|
6,828,000 |
|
|
|
| 2015-02-12 |
13D
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
1,448,991 |
|
|
|
| 2015-01-30 |
13D/A
|
OTIC / Otonomy Inc
|
|
|
2,256,398 |
|
|
|
| 2015-01-23 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
|
5,438,695 |
|
|
|
| 2014-09-19 |
13D
|
AFMD / Affimed N.V.
|
|
|
5,814,630 |
|
|
|
| 2014-08-28 |
13D/A
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
1,485,324 |
|
|
|
| 2014-08-22 |
13D
|
OTIC / Otonomy Inc
|
|
|
2,256,398 |
|
|
|
| 2014-08-19 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
|
8,951,551 |
|
|
|
| 2014-08-08 |
13D
|
LOXO / Loxo Oncology, Inc.
|
|
|
2,175,857 |
|
|
|
| 2014-08-01 |
13D/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,018,417 |
|
|
|
| 2014-07-25 |
13D
|
ROKA / Roka Bioscience, Inc.
|
|
|
3,445,066 |
|
|
|
| 2014-05-19 |
13D/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,099,417 |
|
|
|
| 2014-04-17 |
13D/A
|
RLYP / Relypsa, Inc.
|
|
|
9,941,551 |
|
|
|
| 2014-04-11 |
13D/A
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
1,656,258 |
|
|
|
| 2014-04-10 |
13G/A
|
XTNT / Xtant Medical Holdings, Inc.
|
|
|
5,631,579 |
|
|
|
| 2014-02-14 |
13G/A
|
SQNM / Sequenom, Inc.
|
|
|
0 |
|
|
|
| 2014-02-14 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
|
4,590,800 |
|
|
|
| 2014-02-14 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
1,619,131 |
|
|
|
| 2014-02-14 |
13G/A
|
UPI / Uroplasty Inc
|
|
|
1,443,500 |
|
|
|
| 2014-02-13 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
|
4,592,000 |
|
|
|
| 2014-02-13 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
2,320,800 |
|
|
|
| 2014-02-13 |
13G
|
ARQL / ArQule, Inc.
|
|
|
5,702,000 |
|
|
|
| 2014-02-13 |
13G
|
IPXL / Impax Laboratories, Inc.
|
|
|
4,237,600 |
|
|
|
| 2014-02-13 |
13G
|
ITMN /
|
|
|
7,697,000 |
|
|
|
| 2014-02-13 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
4,794,300 |
|
|
|
| 2014-02-13 |
13G/A
|
OSUR / OraSure Technologies, Inc.
|
|
|
4,988,000 |
|
|
|
| 2014-02-13 |
13G/A
|
EXAS / Exact Sciences Corporation
|
|
|
4,989,300 |
|
|
|
| 2014-02-13 |
13G
|
PODD / Insulet Corporation
|
|
|
2,888,500 |
|
|
|
| 2014-02-13 |
13G/A
|
AFFY / Affymax, Inc.
|
|
|
369,971 |
|
|
|
| 2014-02-13 |
13G/A
|
FLDM / Standard BioTools Inc
|
|
|
1,446,008 |
|
|
|
| 2014-02-13 |
13G
|
MEIP / MEI Pharma, Inc.
|
|
|
1,989,500 |
|
|
|
| 2014-02-13 |
13G
|
XLRN / Acceleron Pharma Inc
|
|
|
2,272,819 |
|
|
|
| 2014-02-13 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,681,035 |
|
|
|
| 2014-02-13 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
|
2,376,500 |
|
|
|
| 2014-02-13 |
13G
|
XTNT / Xtant Medical Holdings, Inc.
|
|
|
4,131,579 |
|
|
|
| 2014-02-13 |
13G
|
DRTX / Durata Therapeutics Inc
|
|
|
1,785,714 |
|
|
|
| 2014-02-13 |
13G
|
PRTA / Prothena Corporation plc
|
|
|
1,202,000 |
|
|
|
| 2014-02-13 |
13G/A
|
NTUS / Natus Medical Inc
|
|
|
0 |
|
|
|
| 2014-02-13 |
13G
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
2,128,900 |
|
|
|
| 2014-02-13 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
|
6,810,000 |
|
|
|
| 2014-02-13 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
2,631,000 |
|
|
|
| 2013-12-02 |
13D
|
RLYP / Relypsa, Inc.
|
|
|
9,941,551 |
|
|
|
| 2013-11-12 |
13D/A
|
NXTM / NxStage Medical, Inc.
|
|
|
2,879,216 |
|
|
|
| 2013-11-12 |
13D/A
|
RPBIF / Response Biomedical Corp.
|
|
|
5,438,695 |
|
|
|
| 2013-10-18 |
13D/A
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
1,775,672 |
|
|
|
| 2013-08-20 |
13D/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
1,122,300 |
|
|
|
| 2013-07-16 |
13D/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
2,067,700 |
|
|
|
| 2013-07-02 |
13D/A
|
NXTM / NxStage Medical, Inc.
|
|
|
3,136,100 |
|
|
|
| 2013-06-05 |
13D/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
2,500,000 |
|
|
|
| 2013-05-30 |
13D
|
02318X100 / Ambit Biosciences Corp
|
|
|
2,123,785 |
|
|
|
| 2013-04-23 |
13D/A
|
SSRX / 3sbio Inc.
|
|
|
|
|
|
|
| 2013-04-23 |
13G
|
NSPR / InspireMD, Inc.
|
|
|
2,376,500 |
|
|
|
| 2013-04-22 |
13D
|
NSPR / InspireMD, Inc.
|
|
|
2,376,500 |
|
|
|
| 2013-04-15 |
13D/A
|
SSRX / 3sbio Inc.
|
|
|
|
|
|
|
| 2013-04-12 |
13D/A
|
SSRX / 3sbio Inc.
|
|
|
|
|
|
|
| 2013-04-11 |
13D/A
|
SSRX / 3sbio Inc.
|
|
|
|
|
|
|
| 2013-04-08 |
13D
|
SSRX / 3sbio Inc.
|
|
|
14,695,100 |
|
|
|
| 2013-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
|
7,934,800 |
|
|
|
| 2013-02-14 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
2,518,000 |
|
|
|
| 2013-02-14 |
13G/A
|
SQNM / Sequenom, Inc.
|
|
|
6,688,000 |
|
|
|
| 2013-02-14 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
3,378,600 |
|
|
|
| 2013-02-14 |
13G/A
|
OSUR / OraSure Technologies, Inc.
|
|
|
5,437,000 |
|
|
|
| 2013-02-14 |
13G/A
|
EXAS / Exact Sciences Corporation
|
|
|
4,379,000 |
|
|
|
| 2013-02-14 |
13G
|
XNPT / XenoPort, Inc.
|
|
|
2,291,000 |
|
|
|
| 2013-02-14 |
13G/A
|
AFFY / Affymax, Inc.
|
|
|
3,000,971 |
|
|
|
| 2013-02-14 |
13G
|
FLDM / Standard BioTools Inc
|
|
|
1,369,200 |
|
|
|
| 2013-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,417,034 |
|
|
|
| 2013-02-14 |
13D/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
3,000,000 |
|
|
|
| 2013-02-14 |
13G/A
|
SSRX / 3sbio Inc.
|
|
|
2,088,300 |
|
|
|
| 2013-02-14 |
13G
|
MAPP / Harbor ETF Trust - Harbor Multi-Asset Explorer ETF
|
|
|
2,829,000 |
|
|
|
| 2013-02-14 |
13G/A
|
CLSN / Imunon Inc
|
|
|
100,000 |
|
|
|
| 2013-02-14 |
13G
|
NTUS / Natus Medical Inc
|
|
|
1,575,700 |
|
|
|
| 2013-02-14 |
13G/A
|
/ VIVUS, Inc.
|
|
|
921,100 |
|
|
|
| 2013-02-14 |
13G
|
UPI / Uroplasty Inc
|
|
|
1,750,500 |
|
|
|
| 2013-02-14 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
|
7,528,131 |
|
|
|
| 2013-02-14 |
13G
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
4,442,900 |
|
|
|
| 2013-02-11 |
13D
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
8,795,334 |
|
|
|
| 2012-12-05 |
13D/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
3,599,998 |
|
|
|
| 2012-10-26 |
13D
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
2,150,634 |
|
|
|
| 2012-10-02 |
13D/A
|
ATHX / Athersys, Inc.
|
|
|
1,035,388 |
|
|
|
| 2012-09-28 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
|
1,620,000 |
|
|
|
| 2012-09-20 |
13D/A
|
|
|
|
1,724,379 |
|
|
|
| 2012-08-15 |
13D/A
|
NXTM / NxStage Medical, Inc.
|
|
|
3,841,254 |
|
|
|
| 2012-07-19 |
13D/A
|
|
|
|
3,019,379 |
|
|
|
| 2012-07-10 |
13G/A
|
|
|
|
0 |
|
|
|
| 2012-07-03 |
13D/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,333,334 |
|
|
|
| 2012-06-19 |
13D/A
|
ATHX / Athersys, Inc.
|
|
|
1,635,388 |
|
|
|
| 2012-06-15 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
|
2,079,031 |
|
|
|
| 2012-05-14 |
13D
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
3,599,998 |
|
|
|
| 2012-03-26 |
13D/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
2,616,634 |
|
|
|
| 2012-03-19 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
|
2,525,033 |
|
|
|
| 2012-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
|
8,619,700 |
|
|
|
| 2012-02-14 |
13G
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
2,135,800 |
|
|
|
| 2012-02-14 |
13G
|
SQNM / Sequenom, Inc.
|
|
|
6,753,000 |
|
|
|
| 2012-02-14 |
13G/A
|
ALTH / Allos Therapeutics Inc
|
|
|
0 |
|
|
|
| 2012-02-14 |
13G
|
OSUR / OraSure Technologies, Inc.
|
|
|
2,908,900 |
|
|
|
| 2012-02-14 |
13G/A
|
EXAS / Exact Sciences Corporation
|
|
|
4,024,500 |
|
|
|
| 2012-02-14 |
13G/A
|
ANDS / Anadys Pharmaceuticals Inc
|
|
|
0 |
|
|
|
| 2012-02-14 |
13G/A
|
TLON / Talon Therapeutics, Inc.
|
|
|
869,644 |
|
|
|
| 2012-02-14 |
13G/A
|
AFFY / Affymax, Inc.
|
|
|
3,196,900 |
|
|
|
| 2012-02-14 |
13G/A
|
INHX / Inhibitex, Inc.
|
|
|
2,544,249 |
|
|
|
| 2012-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
3,897,903 |
|
|
|
| 2012-02-14 |
13G/A
|
SSRX / 3sbio Inc.
|
|
|
2,173,100 |
|
|
|
| 2012-02-14 |
13G/A
|
MAPP / Harbor ETF Trust - Harbor Multi-Asset Explorer ETF
|
|
|
1,408,200 |
|
|
|
| 2012-02-14 |
13G/A
|
|
|
|
6,451,400 |
|
|
|
| 2012-02-14 |
13G
|
CLSN / Imunon Inc
|
|
|
2,270,271 |
|
|
|
| 2012-02-14 |
13G
|
/ VIVUS, Inc.
|
|
|
6,514,000 |
|
|
|
| 2012-02-14 |
13G/A
|
AFFX / Affymetrix, Inc.
|
|
|
6,850,100 |
|
|
|
| 2012-02-14 |
13G/A
|
PCYC / Pharmacyclics
|
|
|
2,179,050 |
|
|
|
